M. Mulroy Dennis's most recent trade in AnaptysBio Inc was a trade of 6,700 Common Stock done . Disclosure was reported to the exchange on Jan. 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 6,700 | 24,367 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 6,700 | 20,100 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.71 per share. | 07 Jan 2026 | 2,515 | 21,852 (0%) | 0% | 44.7 | 112,446 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 29,000 | 29,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 21,400 | 21,400 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,245 | 19,575 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,245 | 5,245 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.11 per share. | 06 Jan 2026 | 1,908 | 17,667 (0%) | 0% | 45.1 | 86,070 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2026 | 8,292 | 17,693 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2026 | 8,292 | 16,585 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.26 per share. | 03 Jan 2026 | 3,363 | 14,330 (0%) | 0% | 43.3 | 145,483 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 10,000 | 60,600 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.16 per share. | 22 Dec 2025 | 10,000 | 19,401 (0%) | 0% | 20.2 | 201,600 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 22 Dec 2025 | 10,000 | 9,401 (0%) | 0% | 50 | 500,000 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 10,000 | 70,600 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.16 per share. | 16 Dec 2025 | 10,000 | 25,126 (0%) | 0% | 20.2 | 201,600 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.62 per share. | 16 Dec 2025 | 9,365 | 15,761 (0%) | 0% | 44.6 | 417,821 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.21 per share. | 16 Dec 2025 | 6,360 | 9,401 (0%) | 0% | 45.2 | 287,511 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 76,400 | 76,400 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 26,800 | 26,800 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 8,293 | 14,018 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 8,293 | 24,877 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 5,245 | 10,490 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 5,245 | 15,856 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.60 per share. | 03 Jan 2025 | 3,407 | 10,611 (0%) | 0% | 14.6 | 49,742 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 03 Jan 2025 | 2,054 | 13,802 (0%) | 0% | 15.3 | 31,426 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 10,000 | 80,600 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 14 Sep 2024 | 10,000 | 4,744 (0%) | 0% | 40.1 | 401,300 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.16 per share. | 14 Sep 2024 | 10,000 | 14,744 (0%) | 0% | 20.2 | 201,600 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 6,000 | 6,964 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.93 per share. | 14 Sep 2024 | 2,220 | 4,744 (0%) | 0% | 38.9 | 86,425 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 20,000 | 20,000 | - | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.72 per share. | 22 May 2024 | 1,500 | 964 (0%) | 0% | 23.7 | 35,580 | Common Stock |
| AnaptysBio Inc | M. Mulroy Dennis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.63 per share. | 30 Jan 2024 | 3,065 | 964 (0%) | 0% | 23.6 | 72,425 | Common Stock |
| AnaptysBio Inc | M. Dennis Mulroy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 5,245 | 6,209 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 5,245 | 15,735 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.81 per share. | 06 Jan 2024 | 2,180 | 4,029 (0%) | 0% | 21.8 | 47,546 | Common Stock |
| AnaptysBio Inc | M. Mulroy Dennis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 90,780 | 90,780 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Mulroy Dennis M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 33,170 | 33,170 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 57,260 | 57,260 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 20,980 | 20,980 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 22.03 per share. | 15 Nov 2021 | 964 | 964 (0%) | 0% | 22.0 | 21,237 | Common Stock |